AstraZeneca
AZN | NYSE
$186.65
+$12.25 (+7.02%)
At close: Oct 30, 2026, 4:00 PM ET
$186.06
-$0.59 (-0.32%)
Pre-market:
Nov 2, 2026, 4:17 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 61.18B | 60.44B | 58.74B | 58.13B | 56.5B | 54.98B | 54.07B | 51.21B | 49.13B | 47.61B | 45.81B | 44.99B | 44.48B | 43.84B | 44.35B | 45.15B | 44.04B | 41.49B | 37.42B | 32.82B | 29.53B | 27.58B |
Cost of Revenue | 12.62B | 11.07B | 10.63B | 10.24B | 10.52B | 10.23B | 10.21B | 9.79B | 8.8B | 8.58B | 8.27B | 8.86B | 9.75B | 10.79B | 12.39B | 14.12B | 14.89B | 14.08B | 12.44B | 9.34B | 6.95B | 5.74B |
Gross Profit | 48.56B | 49.37B | 48.11B | 47.89B | 45.98B | 44.75B | 43.87B | 41.42B | 40.33B | 39.03B | 37.54B | 36.13B | 34.74B | 33.05B | 31.96B | 31.04B | 29.15B | 27.4B | 24.98B | 23.48B | 22.58B | 21.84B |
Operating Income | 13.88B | 14.32B | 13.74B | 12.8B | 11.32B | 10.56B | 10B | 9.2B | 9.05B | 8.76B | 8.19B | 8.05B | 7.34B | 5.43B | 3.76B | 2.37B | -549M | 39M | 1.06B | 2.84B | 5.68B | 5.84B |
Interest Income | 360.01M | 349M | 360M | 301M | 399M | 431M | 458M | 502M | 420M | 384M | 351M | 274M | 188M | 142M | 81M | 51M | 51M | 40M | 43M | 45M | 37M | 52M |
Pretax Income | 12.55B | 12.91B | 12.4B | 11.44B | 10.02B | 9.29B | 8.69B | 7.92B | 7.75B | 7.44B | 6.9B | 6.78B | 6.05B | 4.21B | 2.5B | 1.09B | -1.84B | -1.32B | -265M | 1.54B | 4.39B | 4.59B |
Net Income | 10.42B | 10.39B | 10.23B | 9.4B | 8.3B | 7.77B | 7.04B | 6.5B | 6.44B | 6.33B | 5.96B | 5.9B | 6.16B | 4.7B | 3.29B | 2.04B | -1.25B | -1.06B | 112M | 1.47B | 3.77B | 3.98B |
Selling & General & Admin | 20.42B | 20.95B | 20.51B | 20.42B | 20.48B | 20.53B | 20.53B | 20.5B | 20.14B | 20.19B | 19.76B | 22.55B | 22.03B | 21.72B | 22.49B | 21.71B | 21.51B | 19.9B | 17.97B | 15.52B | 14.14B | 13.68B |
Research & Development | 14.63B | 14.57B | 14.23B | 15.05B | 14.5B | 13.96B | 13.58B | 11.98B | 11.45B | 11.11B | 10.94B | 10.65B | 10.52B | 10.4B | 9.93B | 11.28B | 12.43B | 11.72B | 11.3B | 9.2B | 7.09B | 6.65B |
Other Expenses | -378M | -457M | -381M | -381M | -317M | -298M | -252M | -259M | -304M | -1.03B | -1.34B | -5.12B | -5.16B | -4.5B | -4.21B | -4.32B | -4.25B | -4.26B | -5.34B | -4.08B | -4.33B | -4.32B |
Operating Expenses | 34.68B | 35.05B | 34.36B | 35.09B | 34.66B | 34.19B | 33.86B | 32.22B | 31.28B | 30.27B | 29.35B | 28.08B | 27.39B | 27.63B | 28.2B | 28.67B | 29.7B | 27.36B | 23.92B | 20.64B | 16.9B | 16B |
Interest Expense | 1.73B | 1.74B | 1.69B | 1.65B | 1.67B | 1.68B | 1.74B | 1.76B | 1.69B | 1.68B | 1.63B | 1.53B | 1.48B | 1.36B | 1.33B | 1.3B | 1.29B | 1.31B | 1.28B | 1.25B | 1.24B | 1.24B |
Selling & Marketing Expenses | 587M | 585M | 579M | 569M | 566M | 555M | 555M | 557M | 541M | 540M | 539M | 8.71B | 8.71B | 8.7B | 8.69B | 7.91B | 7.9B | 7.88B | 7.85B | 5.4B | 5.38B | 5.38B |
Cost & Expenses | 47.3B | 46.12B | 45B | 45.33B | 45.18B | 44.42B | 44.07B | 42.01B | 40.08B | 38.85B | 37.62B | 36.94B | 37.14B | 38.41B | 40.59B | 42.78B | 44.59B | 41.45B | 36.36B | 29.98B | 23.85B | 21.75B |
Income Tax Expense | 2.13B | 2.52B | 2.17B | 2.04B | 1.72B | 1.51B | 1.65B | 1.42B | 1.3B | 1.1B | 938M | 876M | -118M | -499M | -792M | -958M | -588M | -261M | -380M | 72M | 624M | 633M |
Shares Outstanding (Basic) | 775.5M | 774.5M | 775M | 781.79M | 775M | 775M | 775M | 777.02M | 777.02M | 774.5M | 774.5M | 774.5M | 775M | 774.5M | 774.5M | 774M | 774.5M | 774M | 773.5M | 748M | 656M | 656M |
Shares Outstanding (Diluted) | 780M | 780.5M | 781M | 780.5M | 779.5M | 780.5M | 781M | 780M | 780M | 780M | 780.5M | 780M | 780M | 780M | 779.5M | 779.5M | 780M | 780.5M | 773.5M | 748M | 659M | 659.5M |
EPS (Basic) | 13.46 | 13.42 | 13.20 | 12.12 | 10.70 | 8.78 | 7.84 | 7.12 | 7.06 | 8.16 | 7.66 | 7.60 | 7.94 | 6.06 | 4.24 | 2.64 | -1.68 | -1.30 | 0.58 | 2.58 | 5.76 | 6.08 |
EPS (Diluted) | 13.32 | 13.28 | 13.08 | 12.04 | 10.62 | 8.72 | 7.78 | 7.08 | 7.02 | 8.12 | 7.64 | 7.58 | 7.92 | 6.04 | 4.22 | 2.62 | -1.68 | -1.30 | 0.56 | 2.56 | 5.74 | 6.06 |
EBITDA | 20.49B | 20.47B | 19.83B | 18.03B | 16.9B | 16.07B | 15.5B | 15.36B | 14.58B | 14.26B | 13.92B | 13.63B | 12.9B | 11.02B | 9.08B | 8.58B | 7.1B | 7.03B | 7.54B | 7.92B | 8.78B | 8.94B |
EBIT | 14.16B | 14.65B | 14.1B | 13.09B | 11.7B | 10.97B | 10.43B | 9.68B | 9.44B | 9.12B | 8.53B | 8.31B | 7.53B | 5.57B | 3.83B | 2.38B | -543M | -11M | 1.01B | 2.79B | 5.63B | 5.83B |
Depreciation & Amortization | 6.33B | 5.82B | 5.73B | 4.94B | 5.2B | 5.09B | 5.07B | 5.68B | 5.14B | 5.14B | 5.39B | 5.31B | 5.37B | 5.45B | 5.25B | 6.19B | 7.65B | 7.04B | 6.53B | 5.14B | 3.15B | 3.11B |
Add to Watchlist
Select watchlists to add or remove AZN